Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H9N5O6 |
Molecular Weight | 331.2405 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CN1C(=O)C(=O)NC2=CC(=C(C=C12)N3C=CN=C3)[N+]([O-])=O
InChI
InChIKey=SPXYHZRWPRQLNS-UHFFFAOYSA-N
InChI=1S/C13H9N5O6/c19-11(20)5-17-8-4-9(16-2-1-14-6-16)10(18(23)24)3-7(8)15-12(21)13(17)22/h1-4,6H,5H2,(H,15,21)(H,19,20)
Molecular Formula | C13H9N5O6 |
Molecular Weight | 331.2405 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Zonampanel (also known as YM872) was developed as selective, potent and highly water-soluble competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist. Zonampanel possesses the neuroprotective effect against focal cerebral ischemia and participated in phase II clinical trials in acute stroke patients. However, because of the severe effects, including hallucinations, agitation, and catatonia the further studied were terminated.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00044057
YM872 (ZONAMPANEL) or placebo will be given as a continuous intravenous (iv) infusion for 24 hours
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:27:57 GMT 2023
by
admin
on
Fri Dec 15 18:27:57 GMT 2023
|
Record UNII |
9X33544ILS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
||
|
NCI_THESAURUS |
C1509
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9X33544ILS
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
PRIMARY | |||
|
C152964
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
PRIMARY | |||
|
148200
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
PRIMARY | |||
|
DTXSID50175232
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
PRIMARY | |||
|
8154
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
PRIMARY | |||
|
210245-80-0
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
PRIMARY | |||
|
Zonampanel
Created by
admin on Fri Dec 15 18:27:57 GMT 2023 , Edited by admin on Fri Dec 15 18:27:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
SOLVATE->ANHYDROUS | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |